Table 3 Association of Clinicopathologic features with survival status of the patients
From: Prognostic significance of p16 immunohistochemical expression in urothelial carcinoma
n (%) | P-Value | ||||
|---|---|---|---|---|---|
Alive (n = 45) | Died of disease (n = 9) | Total (n = 54) | |||
Gender | Male | 35 (77.8) | 7 (77.8) | 42 (77.8) | 1.000 |
Female | 10 (22.2) | 2 (22.2) | 12 (22.2) | ||
Age group | ≤25 years | 0 (0) | 0 (0) | 0 (0) | 0.178 |
26–50 years | 11 (24.4) | 0 (0) | 11 (20.4) | ||
> 50 years | 34 (75.6) | 9 (100) | 43 (79.6) | ||
Tumor grade | Low grade | 27 (60) | 2 (22.2) | 29 (53.7) | 0.065 |
High grade | 18 (40) | 7 (77.8) | 25 (46.3) | ||
Muscularis propria Invasion | Can’t assessed | 18 (40) | 4 (44.4) | 22 (40.7) | 0.541 |
Present | 5 (11.1) | 2 (22.2) | 7 (13) | ||
Absent | 22 (48.9) | 3 (33.3) | 25 (46.3) | ||
Lamina propria Invasion | Present | 11 (24.4) | 4 (44.4) | 15 (27.8) | 0.244 |
Absent | 34 (75.6) | 5 (55.6) | 39 (72.2) | ||
Recurrence | Yes | 14 (31.1) | 9 (100) | 23 (42.6) | 0.000 |
No | 31 (68.9) | 0 (0) | 31 (57.4) | ||
P16 Expression | Low expression | 4 (8.9) | 4 (44.4) | 8 (14.8) | 0.020 |
High expression | 41 (91.1) | 5 (55.6) | 46 (85.2) | ||